nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—ESR1—liver cancer	0.695	1	CbGaD
Danazol—Hoarseness—Sorafenib—liver cancer	0.0042	0.0448	CcSEcCtD
Danazol—Interstitial pneumonia—Sorafenib—liver cancer	0.00383	0.0408	CcSEcCtD
Danazol—Interstitial lung disease—Sorafenib—liver cancer	0.00261	0.0279	CcSEcCtD
Danazol—Oropharyngeal discomfort—Sorafenib—liver cancer	0.00254	0.0271	CcSEcCtD
Danazol—Dysphonia—Sorafenib—liver cancer	0.00225	0.024	CcSEcCtD
Danazol—Pigmentation disorder—Epirubicin—liver cancer	0.00205	0.0218	CcSEcCtD
Danazol—Pigmentation disorder—Doxorubicin—liver cancer	0.00189	0.0202	CcSEcCtD
Danazol—Laboratory test abnormal—Epirubicin—liver cancer	0.00164	0.0174	CcSEcCtD
Danazol—Hepatic function abnormal—Sorafenib—liver cancer	0.00154	0.0164	CcSEcCtD
Danazol—Laboratory test abnormal—Doxorubicin—liver cancer	0.00151	0.0161	CcSEcCtD
Danazol—Mood swings—Sorafenib—liver cancer	0.00127	0.0136	CcSEcCtD
Danazol—Abdominal pain upper—Sorafenib—liver cancer	0.00123	0.0131	CcSEcCtD
Danazol—Gingival bleeding—Epirubicin—liver cancer	0.0012	0.0128	CcSEcCtD
Danazol—Quinestrol—ESR1—liver cancer	0.00117	0.163	CrCbGaD
Danazol—Pancreatitis—Sorafenib—liver cancer	0.00114	0.0121	CcSEcCtD
Danazol—Pelvic pain—Epirubicin—liver cancer	0.00112	0.012	CcSEcCtD
Danazol—Gingival bleeding—Doxorubicin—liver cancer	0.00111	0.0119	CcSEcCtD
Danazol—Pelvic pain—Doxorubicin—liver cancer	0.00104	0.0111	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00103	0.0109	CcSEcCtD
Danazol—Acute coronary syndrome—Sorafenib—liver cancer	0.00102	0.0109	CcSEcCtD
Danazol—Myocardial infarction—Sorafenib—liver cancer	0.00101	0.0108	CcSEcCtD
Danazol—Jaundice—Sorafenib—liver cancer	0.00101	0.0108	CcSEcCtD
Danazol—Seborrhoeic dermatitis—Epirubicin—liver cancer	0.001	0.0107	CcSEcCtD
Danazol—Thrombosis—Epirubicin—liver cancer	0.000966	0.0103	CcSEcCtD
Danazol—Haemoglobin—Sorafenib—liver cancer	0.000933	0.00995	CcSEcCtD
Danazol—Haemorrhage—Sorafenib—liver cancer	0.000929	0.0099	CcSEcCtD
Danazol—Seborrhoeic dermatitis—Doxorubicin—liver cancer	0.000928	0.00989	CcSEcCtD
Danazol—Thrombosis—Doxorubicin—liver cancer	0.000893	0.00953	CcSEcCtD
Danazol—Mestranol—ESR1—liver cancer	0.000888	0.124	CrCbGaD
Danazol—Trilostane—ESR1—liver cancer	0.000888	0.124	CrCbGaD
Danazol—Erythema multiforme—Sorafenib—liver cancer	0.000878	0.00936	CcSEcCtD
Danazol—Desogestrel—ESR1—liver cancer	0.000878	0.122	CrCbGaD
Danazol—Flushing—Sorafenib—liver cancer	0.000862	0.00919	CcSEcCtD
Danazol—Dysphonia—Epirubicin—liver cancer	0.000831	0.00886	CcSEcCtD
Danazol—Alopecia—Sorafenib—liver cancer	0.000821	0.00875	CcSEcCtD
Danazol—Jaundice cholestatic—Epirubicin—liver cancer	0.000778	0.00829	CcSEcCtD
Danazol—Amenorrhoea—Epirubicin—liver cancer	0.000778	0.00829	CcSEcCtD
Danazol—Muscle spasms—Sorafenib—liver cancer	0.000777	0.00829	CcSEcCtD
Danazol—Dysphonia—Doxorubicin—liver cancer	0.000769	0.0082	CcSEcCtD
Danazol—Syncope—Sorafenib—liver cancer	0.000725	0.00773	CcSEcCtD
Danazol—Leukopenia—Sorafenib—liver cancer	0.000724	0.00772	CcSEcCtD
Danazol—Amenorrhoea—Doxorubicin—liver cancer	0.00072	0.00767	CcSEcCtD
Danazol—Jaundice cholestatic—Doxorubicin—liver cancer	0.00072	0.00767	CcSEcCtD
Danazol—Loss of consciousness—Sorafenib—liver cancer	0.000711	0.00758	CcSEcCtD
Danazol—Etonogestrel—ESR1—liver cancer	0.00071	0.0988	CrCbGaD
Danazol—Hypertension—Sorafenib—liver cancer	0.000698	0.00744	CcSEcCtD
Danazol—Arthralgia—Sorafenib—liver cancer	0.000688	0.00734	CcSEcCtD
Danazol—Shock—Sorafenib—liver cancer	0.000649	0.00692	CcSEcCtD
Danazol—Fluid retention—Epirubicin—liver cancer	0.000649	0.00692	CcSEcCtD
Danazol—Thrombocytopenia—Sorafenib—liver cancer	0.000646	0.00689	CcSEcCtD
Danazol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000601	0.00641	CcSEcCtD
Danazol—Fluid retention—Doxorubicin—liver cancer	0.0006	0.0064	CcSEcCtD
Danazol—Dyspepsia—Sorafenib—liver cancer	0.000581	0.00619	CcSEcCtD
Danazol—Fatigue—Sorafenib—liver cancer	0.000569	0.00607	CcSEcCtD
Danazol—Hepatic function abnormal—Epirubicin—liver cancer	0.000568	0.00605	CcSEcCtD
Danazol—Photosensitivity—Epirubicin—liver cancer	0.000565	0.00602	CcSEcCtD
Danazol—Constipation—Sorafenib—liver cancer	0.000564	0.00602	CcSEcCtD
Danazol—Hepatic function abnormal—Doxorubicin—liver cancer	0.000525	0.0056	CcSEcCtD
Danazol—Urticaria—Sorafenib—liver cancer	0.000524	0.00559	CcSEcCtD
Danazol—Photosensitivity—Doxorubicin—liver cancer	0.000523	0.00557	CcSEcCtD
Danazol—Body temperature increased—Sorafenib—liver cancer	0.000522	0.00556	CcSEcCtD
Danazol—Levonorgestrel—ESR1—liver cancer	0.000503	0.0699	CrCbGaD
Danazol—Affect lability—Epirubicin—liver cancer	0.000488	0.00521	CcSEcCtD
Danazol—Migraine—Epirubicin—liver cancer	0.000488	0.00521	CcSEcCtD
Danazol—Fluoxymesterone—ESR1—liver cancer	0.000479	0.0666	CrCbGaD
Danazol—Asthenia—Sorafenib—liver cancer	0.000473	0.00505	CcSEcCtD
Danazol—Mood swings—Epirubicin—liver cancer	0.00047	0.00501	CcSEcCtD
Danazol—Pruritus—Sorafenib—liver cancer	0.000467	0.00498	CcSEcCtD
Danazol—Abdominal pain upper—Epirubicin—liver cancer	0.000453	0.00483	CcSEcCtD
Danazol—Affect lability—Doxorubicin—liver cancer	0.000452	0.00482	CcSEcCtD
Danazol—Migraine—Doxorubicin—liver cancer	0.000452	0.00482	CcSEcCtD
Danazol—Dizziness—Sorafenib—liver cancer	0.000436	0.00465	CcSEcCtD
Danazol—Mood swings—Doxorubicin—liver cancer	0.000435	0.00464	CcSEcCtD
Danazol—Eosinophilia—Epirubicin—liver cancer	0.000425	0.00453	CcSEcCtD
Danazol—Ethinyl Estradiol—ESR1—liver cancer	0.000423	0.0589	CrCbGaD
Danazol—Pancreatitis—Epirubicin—liver cancer	0.00042	0.00448	CcSEcCtD
Danazol—Vomiting—Sorafenib—liver cancer	0.000419	0.00447	CcSEcCtD
Danazol—Abdominal pain upper—Doxorubicin—liver cancer	0.000419	0.00447	CcSEcCtD
Danazol—Rash—Sorafenib—liver cancer	0.000416	0.00444	CcSEcCtD
Danazol—Dermatitis—Sorafenib—liver cancer	0.000416	0.00443	CcSEcCtD
Danazol—Headache—Sorafenib—liver cancer	0.000413	0.00441	CcSEcCtD
Danazol—Eosinophilia—Doxorubicin—liver cancer	0.000393	0.00419	CcSEcCtD
Danazol—Nausea—Sorafenib—liver cancer	0.000392	0.00418	CcSEcCtD
Danazol—Photosensitivity reaction—Epirubicin—liver cancer	0.000391	0.00417	CcSEcCtD
Danazol—Weight increased—Epirubicin—liver cancer	0.00039	0.00416	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—liver cancer	0.000389	0.00415	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000379	0.00404	CcSEcCtD
Danazol—Jaundice—Epirubicin—liver cancer	0.000373	0.00397	CcSEcCtD
Danazol—Sweating—Epirubicin—liver cancer	0.000367	0.00391	CcSEcCtD
Danazol—Haematuria—Epirubicin—liver cancer	0.000365	0.00389	CcSEcCtD
Danazol—Photosensitivity reaction—Doxorubicin—liver cancer	0.000362	0.00386	CcSEcCtD
Danazol—Weight increased—Doxorubicin—liver cancer	0.000361	0.00385	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000351	0.00374	CcSEcCtD
Danazol—Haemoglobin—Epirubicin—liver cancer	0.000345	0.00368	CcSEcCtD
Danazol—Jaundice—Doxorubicin—liver cancer	0.000345	0.00368	CcSEcCtD
Danazol—Haemorrhage—Epirubicin—liver cancer	0.000343	0.00366	CcSEcCtD
Danazol—Sweating—Doxorubicin—liver cancer	0.000339	0.00362	CcSEcCtD
Danazol—Haematuria—Doxorubicin—liver cancer	0.000337	0.0036	CcSEcCtD
Danazol—Visual impairment—Epirubicin—liver cancer	0.000331	0.00353	CcSEcCtD
Danazol—Erythema multiforme—Epirubicin—liver cancer	0.000324	0.00346	CcSEcCtD
Danazol—Haemoglobin—Doxorubicin—liver cancer	0.000319	0.0034	CcSEcCtD
Danazol—Flushing—Epirubicin—liver cancer	0.000319	0.0034	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—liver cancer	0.000318	0.00339	CcSEcCtD
Danazol—Chills—Epirubicin—liver cancer	0.000308	0.00328	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—liver cancer	0.000306	0.00326	CcSEcCtD
Danazol—Alopecia—Epirubicin—liver cancer	0.000303	0.00323	CcSEcCtD
Danazol—Erythema multiforme—Doxorubicin—liver cancer	0.0003	0.0032	CcSEcCtD
Danazol—Flushing—Doxorubicin—liver cancer	0.000295	0.00314	CcSEcCtD
Danazol—Tension—Epirubicin—liver cancer	0.000293	0.00313	CcSEcCtD
Danazol—Nervousness—Epirubicin—liver cancer	0.00029	0.00309	CcSEcCtD
Danazol—Back pain—Epirubicin—liver cancer	0.000289	0.00308	CcSEcCtD
Danazol—Muscle spasms—Epirubicin—liver cancer	0.000287	0.00306	CcSEcCtD
Danazol—Chills—Doxorubicin—liver cancer	0.000285	0.00304	CcSEcCtD
Danazol—Vision blurred—Epirubicin—liver cancer	0.000282	0.003	CcSEcCtD
Danazol—Alopecia—Doxorubicin—liver cancer	0.000281	0.00299	CcSEcCtD
Danazol—Tension—Doxorubicin—liver cancer	0.000271	0.00289	CcSEcCtD
Danazol—Nervousness—Doxorubicin—liver cancer	0.000268	0.00286	CcSEcCtD
Danazol—Vertigo—Epirubicin—liver cancer	0.000268	0.00286	CcSEcCtD
Danazol—Syncope—Epirubicin—liver cancer	0.000268	0.00286	CcSEcCtD
Danazol—Leukopenia—Epirubicin—liver cancer	0.000267	0.00285	CcSEcCtD
Danazol—Back pain—Doxorubicin—liver cancer	0.000267	0.00285	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—liver cancer	0.000266	0.00283	CcSEcCtD
Danazol—Palpitations—Epirubicin—liver cancer	0.000264	0.00282	CcSEcCtD
Danazol—Loss of consciousness—Epirubicin—liver cancer	0.000263	0.0028	CcSEcCtD
Danazol—Vision blurred—Doxorubicin—liver cancer	0.000261	0.00278	CcSEcCtD
Danazol—Convulsion—Epirubicin—liver cancer	0.000259	0.00276	CcSEcCtD
Danazol—Hypertension—Epirubicin—liver cancer	0.000258	0.00275	CcSEcCtD
Danazol—Arthralgia—Epirubicin—liver cancer	0.000254	0.00271	CcSEcCtD
Danazol—Anxiety—Epirubicin—liver cancer	0.000253	0.0027	CcSEcCtD
Danazol—Vertigo—Doxorubicin—liver cancer	0.000248	0.00265	CcSEcCtD
Danazol—Syncope—Doxorubicin—liver cancer	0.000248	0.00264	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—liver cancer	0.000247	0.00264	CcSEcCtD
Danazol—Palpitations—Doxorubicin—liver cancer	0.000244	0.0026	CcSEcCtD
Danazol—Oedema—Epirubicin—liver cancer	0.000244	0.0026	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—liver cancer	0.000243	0.00259	CcSEcCtD
Danazol—Shock—Epirubicin—liver cancer	0.00024	0.00256	CcSEcCtD
Danazol—Convulsion—Doxorubicin—liver cancer	0.00024	0.00255	CcSEcCtD
Danazol—Thrombocytopenia—Epirubicin—liver cancer	0.000239	0.00255	CcSEcCtD
Danazol—Hypertension—Doxorubicin—liver cancer	0.000239	0.00254	CcSEcCtD
Danazol—Tachycardia—Epirubicin—liver cancer	0.000238	0.00254	CcSEcCtD
Danazol—Progesterone—ESR1—liver cancer	0.000237	0.033	CrCbGaD
Danazol—Hyperhidrosis—Epirubicin—liver cancer	0.000236	0.00251	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—liver cancer	0.000235	0.00251	CcSEcCtD
Danazol—Anxiety—Doxorubicin—liver cancer	0.000235	0.0025	CcSEcCtD
Danazol—Oedema—Doxorubicin—liver cancer	0.000226	0.00241	CcSEcCtD
Danazol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000222	0.00237	CcSEcCtD
Danazol—Shock—Doxorubicin—liver cancer	0.000222	0.00237	CcSEcCtD
Danazol—Thrombocytopenia—Doxorubicin—liver cancer	0.000221	0.00236	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—liver cancer	0.00022	0.00235	CcSEcCtD
Danazol—Paraesthesia—Epirubicin—liver cancer	0.000219	0.00233	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—liver cancer	0.000218	0.00233	CcSEcCtD
Danazol—Dyspepsia—Epirubicin—liver cancer	0.000215	0.00229	CcSEcCtD
Danazol—Fatigue—Epirubicin—liver cancer	0.00021	0.00224	CcSEcCtD
Danazol—Constipation—Epirubicin—liver cancer	0.000209	0.00222	CcSEcCtD
Danazol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000206	0.00219	CcSEcCtD
Danazol—Paraesthesia—Doxorubicin—liver cancer	0.000203	0.00216	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—liver cancer	0.000199	0.00212	CcSEcCtD
Danazol—Fatigue—Doxorubicin—liver cancer	0.000195	0.00207	CcSEcCtD
Danazol—Urticaria—Epirubicin—liver cancer	0.000194	0.00207	CcSEcCtD
Danazol—Constipation—Doxorubicin—liver cancer	0.000193	0.00206	CcSEcCtD
Danazol—Body temperature increased—Epirubicin—liver cancer	0.000193	0.00206	CcSEcCtD
Danazol—Progesterone—CYP1A1—liver cancer	0.00019	0.0264	CrCbGaD
Danazol—Prednisone—ALB—liver cancer	0.000184	0.0256	CrCbGaD
Danazol—Norethindrone—ALB—liver cancer	0.000181	0.0252	CrCbGaD
Danazol—Testosterone—CYP1A1—liver cancer	0.000179	0.025	CrCbGaD
Danazol—Urticaria—Doxorubicin—liver cancer	0.000179	0.00191	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—liver cancer	0.000178	0.0019	CcSEcCtD
Danazol—Asthenia—Epirubicin—liver cancer	0.000175	0.00187	CcSEcCtD
Danazol—Pruritus—Epirubicin—liver cancer	0.000173	0.00184	CcSEcCtD
Danazol—Methyltestosterone—ALB—liver cancer	0.000172	0.024	CrCbGaD
Danazol—Asthenia—Doxorubicin—liver cancer	0.000162	0.00173	CcSEcCtD
Danazol—Dizziness—Epirubicin—liver cancer	0.000161	0.00172	CcSEcCtD
Danazol—Pruritus—Doxorubicin—liver cancer	0.00016	0.0017	CcSEcCtD
Danazol—Vomiting—Epirubicin—liver cancer	0.000155	0.00165	CcSEcCtD
Danazol—Rash—Epirubicin—liver cancer	0.000154	0.00164	CcSEcCtD
Danazol—Dermatitis—Epirubicin—liver cancer	0.000154	0.00164	CcSEcCtD
Danazol—Headache—Epirubicin—liver cancer	0.000153	0.00163	CcSEcCtD
Danazol—Dizziness—Doxorubicin—liver cancer	0.000149	0.00159	CcSEcCtD
Danazol—Nausea—Epirubicin—liver cancer	0.000145	0.00154	CcSEcCtD
Danazol—Vomiting—Doxorubicin—liver cancer	0.000143	0.00153	CcSEcCtD
Danazol—Rash—Doxorubicin—liver cancer	0.000142	0.00152	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—liver cancer	0.000142	0.00152	CcSEcCtD
Danazol—Headache—Doxorubicin—liver cancer	0.000141	0.00151	CcSEcCtD
Danazol—Nausea—Doxorubicin—liver cancer	0.000134	0.00143	CcSEcCtD
Danazol—Testosterone—ALB—liver cancer	9.99e-05	0.0139	CrCbGaD
Danazol—CCL2—Signaling Pathways—MAPK14—liver cancer	3.98e-05	0.000195	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.98e-05	0.000195	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ESR1—liver cancer	3.9e-05	0.000191	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—F2—liver cancer	3.86e-05	0.000189	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARG—liver cancer	3.85e-05	0.000188	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTM1—liver cancer	3.83e-05	0.000187	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARA—liver cancer	3.82e-05	0.000187	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	3.78e-05	0.000185	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.75e-05	0.000183	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.75e-05	0.000183	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—liver cancer	3.74e-05	0.000183	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PSMA4—liver cancer	3.73e-05	0.000182	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PSMD10—liver cancer	3.73e-05	0.000182	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—liver cancer	3.7e-05	0.000181	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APC—liver cancer	3.69e-05	0.00018	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CG—liver cancer	3.69e-05	0.00018	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—liver cancer	3.68e-05	0.00018	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—liver cancer	3.66e-05	0.000179	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK14—liver cancer	3.64e-05	0.000178	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HPGDS—liver cancer	3.64e-05	0.000178	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.64e-05	0.000178	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.63e-05	0.000177	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.62e-05	0.000177	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.59e-05	0.000175	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FST—liver cancer	3.57e-05	0.000175	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ESR1—liver cancer	3.57e-05	0.000175	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAPK14—liver cancer	3.53e-05	0.000173	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—F2—liver cancer	3.53e-05	0.000172	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—SERPINE1—liver cancer	3.47e-05	0.00017	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—BRAF—liver cancer	3.47e-05	0.00017	CbGpPWpGaD
Danazol—PGR—Gene Expression—ESR1—liver cancer	3.46e-05	0.000169	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TRIO—liver cancer	3.41e-05	0.000167	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CG—liver cancer	3.37e-05	0.000165	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APC—liver cancer	3.37e-05	0.000165	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.29e-05	0.000161	CbGpPWpGaD
Danazol—AR—Gene Expression—H2AFX—liver cancer	3.27e-05	0.00016	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCR4—liver cancer	3.27e-05	0.00016	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.25e-05	0.000159	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CD—liver cancer	3.24e-05	0.000159	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PSMD10—liver cancer	3.24e-05	0.000159	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PSMA4—liver cancer	3.24e-05	0.000159	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SERPINE1—liver cancer	3.21e-05	0.000157	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKCE—liver cancer	3.2e-05	0.000157	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—KRAS—liver cancer	3.18e-05	0.000155	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—BRAF—liver cancer	3.17e-05	0.000155	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARG—liver cancer	3.16e-05	0.000154	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GOT2—liver cancer	3.15e-05	0.000154	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.07e-05	0.00015	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF2—liver cancer	3.04e-05	0.000148	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CD—liver cancer	2.97e-05	0.000145	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2E1—liver cancer	2.97e-05	0.000145	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—liver cancer	2.94e-05	0.000144	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SERPINE1—liver cancer	2.93e-05	0.000143	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—liver cancer	2.92e-05	0.000143	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARA—liver cancer	2.91e-05	0.000142	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—KRAS—liver cancer	2.9e-05	0.000142	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RAF1—liver cancer	2.9e-05	0.000142	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.87e-05	0.00014	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—liver cancer	2.85e-05	0.000139	CbGpPWpGaD
Danazol—PGR—Gene Expression—SERPINE1—liver cancer	2.85e-05	0.000139	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CSF2—liver cancer	2.83e-05	0.000139	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MTOR—liver cancer	2.83e-05	0.000138	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CB—liver cancer	2.83e-05	0.000138	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—H2AFX—liver cancer	2.79e-05	0.000137	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYCS—liver cancer	2.77e-05	0.000136	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GGT1—liver cancer	2.72e-05	0.000133	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GOT1—liver cancer	2.72e-05	0.000133	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UGDH—liver cancer	2.72e-05	0.000133	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—liver cancer	2.7e-05	0.000132	CbGpPWpGaD
Danazol—AR—Gene Expression—MAPK14—liver cancer	2.69e-05	0.000131	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—liver cancer	2.67e-05	0.00013	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1B—liver cancer	2.65e-05	0.00013	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RAF1—liver cancer	2.65e-05	0.00013	CbGpPWpGaD
Danazol—AR—Gene Expression—ESR1—liver cancer	2.64e-05	0.000129	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—liver cancer	2.6e-05	0.000127	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—liver cancer	2.6e-05	0.000127	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CB—liver cancer	2.59e-05	0.000126	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MTOR—liver cancer	2.59e-05	0.000126	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—liver cancer	2.58e-05	0.000126	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADAM17—liver cancer	2.58e-05	0.000126	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EPT1—liver cancer	2.56e-05	0.000125	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—liver cancer	2.53e-05	0.000124	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—JUN—liver cancer	2.53e-05	0.000123	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TERT—liver cancer	2.53e-05	0.000123	CbGpPWpGaD
Danazol—ESR1—Gene Expression—H2AFX—liver cancer	2.52e-05	0.000123	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CTNNB1—liver cancer	2.51e-05	0.000123	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—liver cancer	2.47e-05	0.000121	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—liver cancer	2.46e-05	0.00012	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1A—liver cancer	2.45e-05	0.00012	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—liver cancer	2.45e-05	0.00012	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSMA4—liver cancer	2.43e-05	0.000119	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PSMD10—liver cancer	2.43e-05	0.000119	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1B—liver cancer	2.43e-05	0.000119	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TAT—liver cancer	2.42e-05	0.000118	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—liver cancer	2.41e-05	0.000118	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—liver cancer	2.41e-05	0.000118	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—liver cancer	2.4e-05	0.000117	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK8—liver cancer	2.39e-05	0.000117	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—liver cancer	2.38e-05	0.000117	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—liver cancer	2.38e-05	0.000116	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—liver cancer	2.37e-05	0.000116	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—liver cancer	2.36e-05	0.000116	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—liver cancer	2.32e-05	0.000113	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—liver cancer	2.31e-05	0.000113	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—liver cancer	2.31e-05	0.000113	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK14—liver cancer	2.3e-05	0.000112	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—liver cancer	2.29e-05	0.000112	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ESR1—liver cancer	2.25e-05	0.00011	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—liver cancer	2.25e-05	0.00011	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—liver cancer	2.25e-05	0.00011	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARA—liver cancer	2.24e-05	0.00011	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—liver cancer	2.24e-05	0.00011	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—F2—liver cancer	2.22e-05	0.000109	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—liver cancer	2.21e-05	0.000108	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—liver cancer	2.2e-05	0.000107	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK8—liver cancer	2.19e-05	0.000107	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—liver cancer	2.19e-05	0.000107	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—liver cancer	2.18e-05	0.000107	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—liver cancer	2.17e-05	0.000106	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A1—liver cancer	2.13e-05	0.000104	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—liver cancer	2.13e-05	0.000104	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CG—liver cancer	2.13e-05	0.000104	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAPK14—liver cancer	2.07e-05	0.000101	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—liver cancer	2.03e-05	9.93e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—liver cancer	2.03e-05	9.9e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—liver cancer	2.02e-05	9.87e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BRAF—liver cancer	2e-05	9.78e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—liver cancer	2e-05	9.77e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—liver cancer	1.99e-05	9.71e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARA—liver cancer	1.95e-05	9.53e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCE—liver cancer	1.88e-05	9.19e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—liver cancer	1.88e-05	9.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CD—liver cancer	1.87e-05	9.15e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—liver cancer	1.86e-05	9.08e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—liver cancer	1.85e-05	9.07e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—liver cancer	1.85e-05	9.06e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—liver cancer	1.85e-05	9.05e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—liver cancer	1.8e-05	8.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—liver cancer	1.78e-05	8.71e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.75e-05	8.56e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—liver cancer	1.72e-05	8.43e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—liver cancer	1.72e-05	8.39e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—liver cancer	1.67e-05	8.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RAF1—liver cancer	1.67e-05	8.17e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CG—liver cancer	1.67e-05	8.16e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—liver cancer	1.67e-05	8.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CSF2—liver cancer	1.66e-05	8.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLUL—liver cancer	1.65e-05	8.05e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CPT1B—liver cancer	1.65e-05	8.05e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—H2AFX—liver cancer	1.64e-05	8.01e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CB—liver cancer	1.63e-05	7.97e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTOR—liver cancer	1.63e-05	7.97e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—liver cancer	1.61e-05	7.87e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—liver cancer	1.59e-05	7.8e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NR1H4—liver cancer	1.59e-05	7.77e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—liver cancer	1.58e-05	7.71e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA3—liver cancer	1.56e-05	7.63e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1B—liver cancer	1.53e-05	7.48e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—liver cancer	1.53e-05	7.46e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—liver cancer	1.53e-05	7.46e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—liver cancer	1.5e-05	7.33e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—liver cancer	1.5e-05	7.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TERT—liver cancer	1.48e-05	7.25e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CD—liver cancer	1.47e-05	7.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—liver cancer	1.46e-05	7.14e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—liver cancer	1.46e-05	7.13e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—liver cancer	1.46e-05	7.12e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—liver cancer	1.45e-05	7.08e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—liver cancer	1.45e-05	7.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA4—liver cancer	1.43e-05	6.98e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—liver cancer	1.42e-05	6.93e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—liver cancer	1.41e-05	6.91e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—liver cancer	1.41e-05	6.88e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—liver cancer	1.4e-05	6.83e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA2—liver cancer	1.39e-05	6.8e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK8—liver cancer	1.38e-05	6.74e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—liver cancer	1.37e-05	6.71e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—liver cancer	1.36e-05	6.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK14—liver cancer	1.35e-05	6.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA1—liver cancer	1.34e-05	6.57e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NAT2—liver cancer	1.33e-05	6.49e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—F2—liver cancer	1.31e-05	6.38e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—liver cancer	1.29e-05	6.3e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CB—liver cancer	1.28e-05	6.25e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALDOB—liver cancer	1.27e-05	6.22e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—liver cancer	1.27e-05	6.22e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—liver cancer	1.26e-05	6.16e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—liver cancer	1.25e-05	6.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CG—liver cancer	1.25e-05	6.11e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—liver cancer	1.25e-05	6.11e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CRABP1—liver cancer	1.21e-05	5.94e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BRAF—liver cancer	1.17e-05	5.74e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—liver cancer	1.17e-05	5.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—liver cancer	1.17e-05	5.71e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CD—liver cancer	1.1e-05	5.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—liver cancer	1.09e-05	5.31e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—liver cancer	1.08e-05	5.29e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HPGDS—liver cancer	1.06e-05	5.19e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—liver cancer	1.06e-05	5.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—liver cancer	9.94e-06	4.86e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RAF1—liver cancer	9.8e-06	4.79e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—liver cancer	9.62e-06	4.7e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CB—liver cancer	9.57e-06	4.68e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTOR—liver cancer	9.57e-06	4.68e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—liver cancer	9.52e-06	4.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSMA4—liver cancer	9.46e-06	4.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PSMD10—liver cancer	9.46e-06	4.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GOT2—liver cancer	9.2e-06	4.5e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—liver cancer	9.2e-06	4.5e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1B—liver cancer	8.98e-06	4.39e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—liver cancer	8.8e-06	4.3e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—liver cancer	8.8e-06	4.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—liver cancer	8.79e-06	4.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2E1—liver cancer	8.65e-06	4.23e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—liver cancer	8.57e-06	4.19e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—liver cancer	8.55e-06	4.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—liver cancer	8.49e-06	4.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—liver cancer	8.32e-06	4.07e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—liver cancer	8.29e-06	4.05e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—liver cancer	8.12e-06	3.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYCS—liver cancer	8.1e-06	3.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK8—liver cancer	8.09e-06	3.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GOT1—liver cancer	7.94e-06	3.88e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GGT1—liver cancer	7.94e-06	3.88e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—liver cancer	7.79e-06	3.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—liver cancer	7.47e-06	3.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—liver cancer	7.4e-06	3.62e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—liver cancer	7.33e-06	3.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—liver cancer	7.14e-06	3.49e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—liver cancer	7.04e-06	3.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—liver cancer	6.87e-06	3.36e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—liver cancer	6.86e-06	3.35e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—liver cancer	6.56e-06	3.21e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—liver cancer	6.37e-06	3.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—liver cancer	6.35e-06	3.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A1—liver cancer	6.22e-06	3.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—liver cancer	5.83e-06	2.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—liver cancer	5.8e-06	2.83e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARA—liver cancer	5.69e-06	2.78e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—liver cancer	5.64e-06	2.76e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—liver cancer	5.4e-06	2.64e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—liver cancer	5.17e-06	2.53e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CG—liver cancer	4.87e-06	2.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—liver cancer	4.77e-06	2.33e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—liver cancer	4.7e-06	2.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CD—liver cancer	4.28e-06	2.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—liver cancer	4.23e-06	2.07e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CB—liver cancer	3.73e-06	1.82e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—liver cancer	2.27e-06	1.11e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—liver cancer	1.86e-06	9.08e-06	CbGpPWpGaD
